Company: RPTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103764
Chunk: 72

Company: Repare Therapeutics Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 72
---
biMed Capital”) is the investment advisor of each of BIOG and OPM. As a result, OrbiMed Capital has the power to direct the vote and disposition of the common shares held by BIOG and OPM and may be deemed directly or indirectly, including by reason of mutual affiliation, to be the beneficial owner of the common shares held by BIOG and OPM. OrbiMed Capital exercises this investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the common shares held by BIOG and OPM. Dr. Bonita is a member of OrbiMed Capital. The address of each of the above persons and entities is 601 Lexington Avenue, 54th Floor, New York, NY 10022 |

| (5) | Consists of (a) 563,403 common shares held by Versant Venture Capital V, L.P. (“Versant V”); (b) 42,877 common shares held by Versant Venture Capital V (Canada) LP (“Versant V Canada”); (c) 18,761 common shares held by Versant Ophthalmic Affiliates Fund I, L.P. (“Versant Ophthalmic”); (d) 16,949 common shares held by Versant Affiliates Fund V, L.P. (“Versant Affiliates V”); (e) 2,094,451 common shares held by Versant Venture Capital VI, L.P. (“Versant VI”); and (f) 231,211 common shares held by Versant Vantage I, L.P. (“Versant Vantage”). Versant V, Versant V Canada, Versant Ophthalmic, Versant Affiliates V, Versant VI and Versant Vantage are collectively referred to as the Versant Entities. Versant Ventures V, LLC is the general partner of each of Versant V, Versant Ophthalmic and Versant Affiliates V and shares voting and dispositive control over the shares held by such entities. Versant Ventures V GP-GP (Canada), |

53

| Inc. is the sole general partner of Versant Ventures V (Canada), L.P., which is the general partner of Versant V Canada, and each of these entities shares voting and dispositive control over the shares held by Versant V Canada. Jerel Davis, Ph.D., Brad Bolzon,